nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.253	0.442	CbGbCtD
Carteolol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0938	0.164	CbGbCtD
Carteolol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0866	0.151	CbGbCtD
Carteolol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0711	0.124	CbGbCtD
Carteolol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0682	0.119	CbGbCtD
Carteolol—Nadolol—ADRB3—type 2 diabetes mellitus	0.00249	0.238	CrCbGaD
Carteolol—Bupranolol—ADRB3—type 2 diabetes mellitus	0.00238	0.227	CrCbGaD
Carteolol—Bopindolol—ADRB3—type 2 diabetes mellitus	0.00228	0.217	CrCbGaD
Carteolol—Hypoglycaemia—Pioglitazone—type 2 diabetes mellitus	0.00195	0.00646	CcSEcCtD
Carteolol—Cerebrovascular accident—Pioglitazone—type 2 diabetes mellitus	0.00194	0.00643	CcSEcCtD
Carteolol—Diabetes mellitus—Bromocriptine—type 2 diabetes mellitus	0.00192	0.00637	CcSEcCtD
Carteolol—Hypoglycaemia—Glimepiride—type 2 diabetes mellitus	0.00189	0.00629	CcSEcCtD
Carteolol—Hypoglycaemia—Sitagliptin—type 2 diabetes mellitus	0.00189	0.00627	CcSEcCtD
Carteolol—Cerebrovascular accident—Glimepiride—type 2 diabetes mellitus	0.00189	0.00627	CcSEcCtD
Carteolol—Cardiac failure congestive—Bromocriptine—type 2 diabetes mellitus	0.00184	0.00611	CcSEcCtD
Carteolol—Visual disturbance—Bromocriptine—type 2 diabetes mellitus	0.00176	0.00585	CcSEcCtD
Carteolol—Sinusitis—Repaglinide—type 2 diabetes mellitus	0.00173	0.00575	CcSEcCtD
Carteolol—Hypoglycaemia—Bromocriptine—type 2 diabetes mellitus	0.00171	0.00568	CcSEcCtD
Carteolol—Cerebrovascular accident—Bromocriptine—type 2 diabetes mellitus	0.0017	0.00565	CcSEcCtD
Carteolol—Diplopia—Bromocriptine—type 2 diabetes mellitus	0.00167	0.00554	CcSEcCtD
Carteolol—Sinusitis—Rosiglitazone—type 2 diabetes mellitus	0.00164	0.00543	CcSEcCtD
Carteolol—Visual disturbance—Glyburide—type 2 diabetes mellitus	0.00161	0.00534	CcSEcCtD
Carteolol—Visual impairment—Repaglinide—type 2 diabetes mellitus	0.0016	0.0053	CcSEcCtD
Carteolol—Pindolol—ADRB3—type 2 diabetes mellitus	0.00157	0.15	CrCbGaD
Carteolol—Hypoglycaemia—Glyburide—type 2 diabetes mellitus	0.00156	0.00519	CcSEcCtD
Carteolol—Diplopia—Glyburide—type 2 diabetes mellitus	0.00153	0.00506	CcSEcCtD
Carteolol—Conjunctivitis—Glipizide—type 2 diabetes mellitus	0.00148	0.00493	CcSEcCtD
Carteolol—Arrhythmia—Repaglinide—type 2 diabetes mellitus	0.00148	0.00491	CcSEcCtD
Carteolol—Palpitations—Nateglinide—type 2 diabetes mellitus	0.00147	0.00489	CcSEcCtD
Carteolol—Visual disturbance—Gliclazide—type 2 diabetes mellitus	0.00145	0.0048	CcSEcCtD
Carteolol—Diabetes mellitus—Orlistat—type 2 diabetes mellitus	0.00143	0.00475	CcSEcCtD
Carteolol—Depression—Sitagliptin—type 2 diabetes mellitus	0.00142	0.0047	CcSEcCtD
Carteolol—Oedema—Acarbose—type 2 diabetes mellitus	0.00141	0.00468	CcSEcCtD
Carteolol—Hypoglycaemia—Gliclazide—type 2 diabetes mellitus	0.0014	0.00466	CcSEcCtD
Carteolol—Cerebrovascular accident—Gliclazide—type 2 diabetes mellitus	0.0014	0.00464	CcSEcCtD
Carteolol—Sinusitis—Pioglitazone—type 2 diabetes mellitus	0.00137	0.00456	CcSEcCtD
Carteolol—Diplopia—Gliclazide—type 2 diabetes mellitus	0.00137	0.00455	CcSEcCtD
Carteolol—Sinusitis—Sitagliptin—type 2 diabetes mellitus	0.00133	0.00443	CcSEcCtD
Carteolol—Visual impairment—Glipizide—type 2 diabetes mellitus	0.00132	0.00439	CcSEcCtD
Carteolol—Bradycardia—Glimepiride—type 2 diabetes mellitus	0.0013	0.00432	CcSEcCtD
Carteolol—Palpitations—Repaglinide—type 2 diabetes mellitus	0.00127	0.00423	CcSEcCtD
Carteolol—Hypoglycaemia—Orlistat—type 2 diabetes mellitus	0.00127	0.00423	CcSEcCtD
Carteolol—Visual impairment—Pioglitazone—type 2 diabetes mellitus	0.00127	0.0042	CcSEcCtD
Carteolol—Diabetes mellitus—Irbesartan—type 2 diabetes mellitus	0.00124	0.00413	CcSEcCtD
Carteolol—Visual impairment—Glimepiride—type 2 diabetes mellitus	0.00123	0.00409	CcSEcCtD
Carteolol—Arrhythmia—Glipizide—type 2 diabetes mellitus	0.00122	0.00407	CcSEcCtD
Carteolol—Sinusitis—Bromocriptine—type 2 diabetes mellitus	0.00121	0.004	CcSEcCtD
Carteolol—Oedema—Repaglinide—type 2 diabetes mellitus	0.00118	0.00391	CcSEcCtD
Carteolol—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.00117	0.0039	CcSEcCtD
Carteolol—Hypoglycaemia—Metformin—type 2 diabetes mellitus	0.00117	0.0039	CcSEcCtD
Carteolol—Diabetes mellitus—Losartan—type 2 diabetes mellitus	0.00117	0.00388	CcSEcCtD
Carteolol—Arrhythmia—Glimepiride—type 2 diabetes mellitus	0.00114	0.00379	CcSEcCtD
Carteolol—Visual disturbance—Irbesartan—type 2 diabetes mellitus	0.00114	0.00379	CcSEcCtD
Carteolol—Vision blurred—Glipizide—type 2 diabetes mellitus	0.00112	0.00373	CcSEcCtD
Carteolol—Oedema—Rosiglitazone—type 2 diabetes mellitus	0.00111	0.00369	CcSEcCtD
Carteolol—Visual impairment—Bromocriptine—type 2 diabetes mellitus	0.00111	0.00369	CcSEcCtD
Carteolol—Cerebrovascular accident—Irbesartan—type 2 diabetes mellitus	0.0011	0.00366	CcSEcCtD
Carteolol—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00107	0.00355	CcSEcCtD
Carteolol—Syncope—Glipizide—type 2 diabetes mellitus	0.00107	0.00355	CcSEcCtD
Carteolol—Nausea—Miglitol—type 2 diabetes mellitus	0.00107	0.00354	CcSEcCtD
Carteolol—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.00106	0.00351	CcSEcCtD
Carteolol—Asthenia—Tolazamide—type 2 diabetes mellitus	0.00105	0.0035	CcSEcCtD
Carteolol—Depression—Gliclazide—type 2 diabetes mellitus	0.00105	0.00349	CcSEcCtD
Carteolol—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.00105	0.00348	CcSEcCtD
Carteolol—Loss of consciousness—Glipizide—type 2 diabetes mellitus	0.00105	0.00348	CcSEcCtD
Carteolol—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.00105	0.00347	CcSEcCtD
Carteolol—Hypoglycaemia—Losartan—type 2 diabetes mellitus	0.00104	0.00346	CcSEcCtD
Carteolol—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00104	0.00345	CcSEcCtD
Carteolol—Arrhythmia—Bromocriptine—type 2 diabetes mellitus	0.00103	0.00342	CcSEcCtD
Carteolol—Conjunctivitis—Gliclazide—type 2 diabetes mellitus	0.00103	0.00341	CcSEcCtD
Carteolol—Visual impairment—Glyburide—type 2 diabetes mellitus	0.00102	0.00338	CcSEcCtD
Carteolol—Headache—Tolbutamide—type 2 diabetes mellitus	0.00101	0.00336	CcSEcCtD
Carteolol—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.001	0.00333	CcSEcCtD
Carteolol—Sinusitis—Gliclazide—type 2 diabetes mellitus	0.00099	0.00329	CcSEcCtD
Carteolol—Palpitations—Glimepiride—type 2 diabetes mellitus	0.000984	0.00327	CcSEcCtD
Carteolol—Dysgeusia—Bromocriptine—type 2 diabetes mellitus	0.000984	0.00327	CcSEcCtD
Carteolol—Loss of consciousness—Glimepiride—type 2 diabetes mellitus	0.000979	0.00325	CcSEcCtD
Carteolol—Asthenia—Nateglinide—type 2 diabetes mellitus	0.000976	0.00324	CcSEcCtD
Carteolol—Oedema—Glipizide—type 2 diabetes mellitus	0.000974	0.00323	CcSEcCtD
Carteolol—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000971	0.00322	CcSEcCtD
Carteolol—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000971	0.00322	CcSEcCtD
Carteolol—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.000964	0.0032	CcSEcCtD
Carteolol—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000958	0.00318	CcSEcCtD
Carteolol—Shock—Glipizide—type 2 diabetes mellitus	0.000958	0.00318	CcSEcCtD
Carteolol—Depression—Orlistat—type 2 diabetes mellitus	0.000955	0.00317	CcSEcCtD
Carteolol—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.000947	0.00314	CcSEcCtD
Carteolol—Oedema—Pioglitazone—type 2 diabetes mellitus	0.000933	0.0031	CcSEcCtD
Carteolol—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00092	0.00305	CcSEcCtD
Carteolol—Headache—Tolazamide—type 2 diabetes mellitus	0.00092	0.00305	CcSEcCtD
Carteolol—Visual impairment—Gliclazide—type 2 diabetes mellitus	0.000913	0.00303	CcSEcCtD
Carteolol—Headache—Linagliptin—type 2 diabetes mellitus	0.00091	0.00302	CcSEcCtD
Carteolol—Sinusitis—Valsartan—type 2 diabetes mellitus	0.00091	0.00302	CcSEcCtD
Carteolol—Syncope—Bromocriptine—type 2 diabetes mellitus	0.000901	0.00299	CcSEcCtD
Carteolol—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000899	0.00299	CcSEcCtD
Carteolol—Sinusitis—Orlistat—type 2 diabetes mellitus	0.000899	0.00298	CcSEcCtD
Carteolol—Shock—Glimepiride—type 2 diabetes mellitus	0.000894	0.00297	CcSEcCtD
Carteolol—Hypoglycaemia—Ramipril—type 2 diabetes mellitus	0.000894	0.00297	CcSEcCtD
Carteolol—Cerebrovascular accident—Ramipril—type 2 diabetes mellitus	0.00089	0.00296	CcSEcCtD
Carteolol—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.000883	0.00293	CcSEcCtD
Carteolol—Insomnia—Glipizide—type 2 diabetes mellitus	0.000881	0.00292	CcSEcCtD
Carteolol—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000872	0.0029	CcSEcCtD
Carteolol—Nausea—Tolazamide—type 2 diabetes mellitus	0.000872	0.0029	CcSEcCtD
Carteolol—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000868	0.00288	CcSEcCtD
Carteolol—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000867	0.00288	CcSEcCtD
Carteolol—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000866	0.00287	CcSEcCtD
Carteolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.000856	0.0816	CrCbGaD
Carteolol—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000849	0.00282	CcSEcCtD
Carteolol—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000846	0.00281	CcSEcCtD
Carteolol—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000844	0.0028	CcSEcCtD
Carteolol—Nausea—Acarbose—type 2 diabetes mellitus	0.000838	0.00278	CcSEcCtD
Carteolol—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000832	0.00276	CcSEcCtD
Carteolol—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000822	0.00273	CcSEcCtD
Carteolol—Oedema—Bromocriptine—type 2 diabetes mellitus	0.00082	0.00272	CcSEcCtD
Carteolol—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000819	0.00272	CcSEcCtD
Carteolol—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.00081	0.00269	CcSEcCtD
Carteolol—Conjunctivitis—Irbesartan—type 2 diabetes mellitus	0.00081	0.00269	CcSEcCtD
Carteolol—Nausea—Nateglinide—type 2 diabetes mellitus	0.000808	0.00268	CcSEcCtD
Carteolol—Bradycardia—Metformin—type 2 diabetes mellitus	0.000807	0.00268	CcSEcCtD
Carteolol—Shock—Bromocriptine—type 2 diabetes mellitus	0.000807	0.00268	CcSEcCtD
Carteolol—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000798	0.00265	CcSEcCtD
Carteolol—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000766	0.00254	CcSEcCtD
Carteolol—Conjunctivitis—Losartan—type 2 diabetes mellitus	0.000762	0.00253	CcSEcCtD
Carteolol—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000761	0.00253	CcSEcCtD
Carteolol—Oedema—Glyburide—type 2 diabetes mellitus	0.00075	0.00249	CcSEcCtD
Carteolol—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000742	0.00246	CcSEcCtD
Carteolol—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.000742	0.00246	CcSEcCtD
Carteolol—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000742	0.00246	CcSEcCtD
Carteolol—Headache—Repaglinide—type 2 diabetes mellitus	0.000737	0.00245	CcSEcCtD
Carteolol—Shock—Glyburide—type 2 diabetes mellitus	0.000737	0.00245	CcSEcCtD
Carteolol—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000736	0.00244	CcSEcCtD
Carteolol—Sinusitis—Losartan—type 2 diabetes mellitus	0.000736	0.00244	CcSEcCtD
Carteolol—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000733	0.00243	CcSEcCtD
Carteolol—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000731	0.00243	CcSEcCtD
Carteolol—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000729	0.00242	CcSEcCtD
Carteolol—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000725	0.00241	CcSEcCtD
Carteolol—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000721	0.00239	CcSEcCtD
Carteolol—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000718	0.00238	CcSEcCtD
Carteolol—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000714	0.00237	CcSEcCtD
Carteolol—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000706	0.00234	CcSEcCtD
Carteolol—Hypotension—Glyburide—type 2 diabetes mellitus	0.0007	0.00233	CcSEcCtD
Carteolol—Nausea—Repaglinide—type 2 diabetes mellitus	0.000699	0.00232	CcSEcCtD
Carteolol—Asthenia—Glipizide—type 2 diabetes mellitus	0.000699	0.00232	CcSEcCtD
Carteolol—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000697	0.00231	CcSEcCtD
Carteolol—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000687	0.00228	CcSEcCtD
Carteolol—Syncope—Valsartan—type 2 diabetes mellitus	0.000679	0.00226	CcSEcCtD
Carteolol—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000676	0.00224	CcSEcCtD
Carteolol—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00067	0.00222	CcSEcCtD
Carteolol—Palpitations—Valsartan—type 2 diabetes mellitus	0.00067	0.00222	CcSEcCtD
Carteolol—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000669	0.00222	CcSEcCtD
Carteolol—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000668	0.00222	CcSEcCtD
Carteolol—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000668	0.00222	CcSEcCtD
Carteolol—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000667	0.00222	CcSEcCtD
Carteolol—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000666	0.00221	CcSEcCtD
Carteolol—Palpitations—Orlistat—type 2 diabetes mellitus	0.000662	0.0022	CcSEcCtD
Carteolol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000661	0.00219	CcSEcCtD
Carteolol—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000654	0.00217	CcSEcCtD
Carteolol—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000652	0.00217	CcSEcCtD
Carteolol—Vision blurred—Metformin—type 2 diabetes mellitus	0.00065	0.00216	CcSEcCtD
Carteolol—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00065	0.00216	CcSEcCtD
Carteolol—Dizziness—Glipizide—type 2 diabetes mellitus	0.000644	0.00214	CcSEcCtD
Carteolol—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000638	0.00212	CcSEcCtD
Carteolol—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000631	0.00209	CcSEcCtD
Carteolol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000629	0.00209	CcSEcCtD
Carteolol—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000629	0.00209	CcSEcCtD
Carteolol—Syncope—Metformin—type 2 diabetes mellitus	0.000619	0.00205	CcSEcCtD
Carteolol—Oedema—Valsartan—type 2 diabetes mellitus	0.000618	0.00205	CcSEcCtD
Carteolol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000617	0.00205	CcSEcCtD
Carteolol—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000614	0.00204	CcSEcCtD
Carteolol—Oedema—Orlistat—type 2 diabetes mellitus	0.000611	0.00203	CcSEcCtD
Carteolol—Headache—Glipizide—type 2 diabetes mellitus	0.00061	0.00203	CcSEcCtD
Carteolol—Palpitations—Metformin—type 2 diabetes mellitus	0.00061	0.00202	CcSEcCtD
Carteolol—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000609	0.00202	CcSEcCtD
Carteolol—Shock—Valsartan—type 2 diabetes mellitus	0.000608	0.00202	CcSEcCtD
Carteolol—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000606	0.00201	CcSEcCtD
Carteolol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000601	0.002	CcSEcCtD
Carteolol—Dysgeusia—Losartan—type 2 diabetes mellitus	0.0006	0.00199	CcSEcCtD
Carteolol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.0006	0.00199	CcSEcCtD
Carteolol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000599	0.00199	CcSEcCtD
Carteolol—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000588	0.00195	CcSEcCtD
Carteolol—Headache—Pioglitazone—type 2 diabetes mellitus	0.000584	0.00194	CcSEcCtD
Carteolol—Syncope—Irbesartan—type 2 diabetes mellitus	0.000584	0.00194	CcSEcCtD
Carteolol—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000582	0.00193	CcSEcCtD
Carteolol—Nausea—Glipizide—type 2 diabetes mellitus	0.000578	0.00192	CcSEcCtD
Carteolol—Hypotension—Valsartan—type 2 diabetes mellitus	0.000578	0.00192	CcSEcCtD
Carteolol—Vision blurred—Losartan—type 2 diabetes mellitus	0.000577	0.00192	CcSEcCtD
Carteolol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000572	0.0019	CcSEcCtD
Carteolol—Headache—Glimepiride—type 2 diabetes mellitus	0.000569	0.00189	CcSEcCtD
Carteolol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000568	0.00188	CcSEcCtD
Carteolol—Oedema—Metformin—type 2 diabetes mellitus	0.000563	0.00187	CcSEcCtD
Carteolol—Insomnia—Valsartan—type 2 diabetes mellitus	0.000559	0.00186	CcSEcCtD
Carteolol—Shock—Metformin—type 2 diabetes mellitus	0.000554	0.00184	CcSEcCtD
Carteolol—Insomnia—Orlistat—type 2 diabetes mellitus	0.000553	0.00183	CcSEcCtD
Carteolol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000552	0.00183	CcSEcCtD
Carteolol—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000551	0.00183	CcSEcCtD
Carteolol—Syncope—Losartan—type 2 diabetes mellitus	0.00055	0.00182	CcSEcCtD
Carteolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000542	0.0018	CcSEcCtD
Carteolol—Palpitations—Losartan—type 2 diabetes mellitus	0.000542	0.0018	CcSEcCtD
Carteolol—Nausea—Glimepiride—type 2 diabetes mellitus	0.00054	0.00179	CcSEcCtD
Carteolol—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000539	0.00179	CcSEcCtD
Carteolol—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000539	0.00179	CcSEcCtD
Carteolol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000538	0.00179	CcSEcCtD
Carteolol—Asthenia—Glyburide—type 2 diabetes mellitus	0.000538	0.00179	CcSEcCtD
Carteolol—Oedema—Irbesartan—type 2 diabetes mellitus	0.000531	0.00176	CcSEcCtD
Carteolol—Hypotension—Metformin—type 2 diabetes mellitus	0.000526	0.00175	CcSEcCtD
Carteolol—Shock—Irbesartan—type 2 diabetes mellitus	0.000523	0.00174	CcSEcCtD
Carteolol—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000515	0.00171	CcSEcCtD
Carteolol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000514	0.00171	CcSEcCtD
Carteolol—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000502	0.00167	CcSEcCtD
Carteolol—Oedema—Losartan—type 2 diabetes mellitus	0.0005	0.00166	CcSEcCtD
Carteolol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000497	0.00165	CcSEcCtD
Carteolol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000496	0.00165	CcSEcCtD
Carteolol—Shock—Losartan—type 2 diabetes mellitus	0.000492	0.00163	CcSEcCtD
Carteolol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000487	0.00162	CcSEcCtD
Carteolol—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000483	0.0016	CcSEcCtD
Carteolol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000474	0.00157	CcSEcCtD
Carteolol—Syncope—Ramipril—type 2 diabetes mellitus	0.000471	0.00156	CcSEcCtD
Carteolol—Headache—Glyburide—type 2 diabetes mellitus	0.00047	0.00156	CcSEcCtD
Carteolol—Hypotension—Losartan—type 2 diabetes mellitus	0.000467	0.00155	CcSEcCtD
Carteolol—Salbutamol—CYP3A4—type 2 diabetes mellitus	0.000466	0.0444	CrCbGaD
Carteolol—Palpitations—Ramipril—type 2 diabetes mellitus	0.000464	0.00154	CcSEcCtD
Carteolol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000462	0.00153	CcSEcCtD
Carteolol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000456	0.00151	CcSEcCtD
Carteolol—Insomnia—Losartan—type 2 diabetes mellitus	0.000452	0.0015	CcSEcCtD
Carteolol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00045	0.00149	CcSEcCtD
Carteolol—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000446	0.00148	CcSEcCtD
Carteolol—Nausea—Glyburide—type 2 diabetes mellitus	0.000445	0.00148	CcSEcCtD
Carteolol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000445	0.00148	CcSEcCtD
Carteolol—Asthenia—Valsartan—type 2 diabetes mellitus	0.000444	0.00147	CcSEcCtD
Carteolol—Asthenia—Orlistat—type 2 diabetes mellitus	0.000438	0.00146	CcSEcCtD
Carteolol—Oedema—Ramipril—type 2 diabetes mellitus	0.000429	0.00142	CcSEcCtD
Carteolol—Shock—Ramipril—type 2 diabetes mellitus	0.000422	0.0014	CcSEcCtD
Carteolol—Headache—Gliclazide—type 2 diabetes mellitus	0.000422	0.0014	CcSEcCtD
Carteolol—Dizziness—Valsartan—type 2 diabetes mellitus	0.000409	0.00136	CcSEcCtD
Carteolol—Dizziness—Orlistat—type 2 diabetes mellitus	0.000404	0.00134	CcSEcCtD
Carteolol—Asthenia—Metformin—type 2 diabetes mellitus	0.000404	0.00134	CcSEcCtD
Carteolol—Hypotension—Ramipril—type 2 diabetes mellitus	0.000401	0.00133	CcSEcCtD
Carteolol—Nausea—Gliclazide—type 2 diabetes mellitus	0.0004	0.00133	CcSEcCtD
Carteolol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000392	0.0013	CcSEcCtD
Carteolol—Insomnia—Ramipril—type 2 diabetes mellitus	0.000388	0.00129	CcSEcCtD
Carteolol—Headache—Valsartan—type 2 diabetes mellitus	0.000387	0.00129	CcSEcCtD
Carteolol—Headache—Orlistat—type 2 diabetes mellitus	0.000383	0.00127	CcSEcCtD
Carteolol—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000382	0.00127	CcSEcCtD
Carteolol—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000381	0.00127	CcSEcCtD
Carteolol—Dizziness—Metformin—type 2 diabetes mellitus	0.000372	0.00124	CcSEcCtD
Carteolol—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000368	0.00122	CcSEcCtD
Carteolol—Nausea—Valsartan—type 2 diabetes mellitus	0.000367	0.00122	CcSEcCtD
Carteolol—Nausea—Orlistat—type 2 diabetes mellitus	0.000363	0.00121	CcSEcCtD
Carteolol—Asthenia—Losartan—type 2 diabetes mellitus	0.000359	0.00119	CcSEcCtD
Carteolol—Headache—Metformin—type 2 diabetes mellitus	0.000353	0.00117	CcSEcCtD
Carteolol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000351	0.00117	CcSEcCtD
Carteolol—Nausea—Metformin—type 2 diabetes mellitus	0.000334	0.00111	CcSEcCtD
Carteolol—Headache—Irbesartan—type 2 diabetes mellitus	0.000333	0.00111	CcSEcCtD
Carteolol—Dizziness—Losartan—type 2 diabetes mellitus	0.000331	0.0011	CcSEcCtD
Carteolol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000316	0.00105	CcSEcCtD
Carteolol—Nausea—Irbesartan—type 2 diabetes mellitus	0.000316	0.00105	CcSEcCtD
Carteolol—Headache—Losartan—type 2 diabetes mellitus	0.000313	0.00104	CcSEcCtD
Carteolol—Asthenia—Ramipril—type 2 diabetes mellitus	0.000308	0.00102	CcSEcCtD
Carteolol—Nausea—Losartan—type 2 diabetes mellitus	0.000297	0.000986	CcSEcCtD
Carteolol—Dizziness—Ramipril—type 2 diabetes mellitus	0.000284	0.000942	CcSEcCtD
Carteolol—Propranolol—CYP1A2—type 2 diabetes mellitus	0.000269	0.0257	CrCbGaD
Carteolol—Headache—Ramipril—type 2 diabetes mellitus	0.000269	0.000892	CcSEcCtD
Carteolol—Nausea—Ramipril—type 2 diabetes mellitus	0.000255	0.000846	CcSEcCtD
Carteolol—Propranolol—CYP3A4—type 2 diabetes mellitus	0.000178	0.017	CrCbGaD
Carteolol—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	4.77e-05	0.000413	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HBA2—type 2 diabetes mellitus	4.77e-05	0.000413	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.77e-05	0.000413	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	4.77e-05	0.000413	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	4.74e-05	0.000411	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	4.73e-05	0.00041	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	4.69e-05	0.000407	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	4.69e-05	0.000407	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RBP4—type 2 diabetes mellitus	4.68e-05	0.000405	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	4.68e-05	0.000405	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AVP—type 2 diabetes mellitus	4.67e-05	0.000404	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	4.67e-05	0.000404	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	4.64e-05	0.000402	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	4.63e-05	0.000401	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	4.62e-05	0.0004	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	4.6e-05	0.000399	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RBP4—type 2 diabetes mellitus	4.57e-05	0.000396	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	4.57e-05	0.000396	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	4.56e-05	0.000396	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AVP—type 2 diabetes mellitus	4.56e-05	0.000396	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	4.54e-05	0.000394	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	4.5e-05	0.00039	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	4.44e-05	0.000385	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	4.37e-05	0.000379	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	4.36e-05	0.000378	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	4.36e-05	0.000378	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	4.34e-05	0.000376	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	4.27e-05	0.00037	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—C3—type 2 diabetes mellitus	4.27e-05	0.00037	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	4.25e-05	0.000368	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	4.22e-05	0.000365	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—C3—type 2 diabetes mellitus	4.18e-05	0.000362	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	4.17e-05	0.000361	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IAPP—type 2 diabetes mellitus	4.14e-05	0.000359	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	4.12e-05	0.000357	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—INSR—type 2 diabetes mellitus	4.12e-05	0.000357	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	4.08e-05	0.000353	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	4.06e-05	0.000352	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	4.06e-05	0.000352	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	4.06e-05	0.000352	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	4.06e-05	0.000352	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	4.05e-05	0.000351	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	4.04e-05	0.000351	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	4.04e-05	0.00035	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	4.03e-05	0.000349	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	4.02e-05	0.000349	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.97e-05	0.000344	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.97e-05	0.000344	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.96e-05	0.000343	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.95e-05	0.000343	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.93e-05	0.000341	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	3.89e-05	0.000337	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	3.89e-05	0.000337	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.88e-05	0.000336	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—C3—type 2 diabetes mellitus	3.88e-05	0.000336	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.85e-05	0.000334	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	3.79e-05	0.000329	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.77e-05	0.000326	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.75e-05	0.000325	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	3.74e-05	0.000324	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	3.74e-05	0.000324	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.74e-05	0.000324	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.74e-05	0.000324	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AGT—type 2 diabetes mellitus	3.68e-05	0.000319	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	3.68e-05	0.000319	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.67e-05	0.000318	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.66e-05	0.000317	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.66e-05	0.000317	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.64e-05	0.000315	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	3.62e-05	0.000314	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.62e-05	0.000314	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	3.62e-05	0.000313	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	3.62e-05	0.000313	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	3.62e-05	0.000313	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	3.6e-05	0.000312	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.56e-05	0.000308	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.56e-05	0.000308	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.54e-05	0.000307	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.54e-05	0.000307	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	3.54e-05	0.000307	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.54e-05	0.000307	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	3.5e-05	0.000303	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.48e-05	0.000302	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.47e-05	0.0003	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.47e-05	0.0003	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	3.42e-05	0.000297	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.4e-05	0.000295	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	3.4e-05	0.000295	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.33e-05	0.000289	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.3e-05	0.000286	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.28e-05	0.000284	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	3.24e-05	0.000281	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.24e-05	0.000281	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.23e-05	0.00028	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.21e-05	0.000278	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.19e-05	0.000276	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	3.18e-05	0.000276	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.18e-05	0.000276	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	3.17e-05	0.000275	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.17e-05	0.000275	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.12e-05	0.00027	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.11e-05	0.00027	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	3.07e-05	0.000266	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	3.07e-05	0.000266	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	3.07e-05	0.000266	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	3.07e-05	0.000266	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.03e-05	0.000263	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.98e-05	0.000258	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.98e-05	0.000258	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.97e-05	0.000257	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	2.95e-05	0.000255	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.92e-05	0.000253	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.91e-05	0.000252	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.82e-05	0.000244	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.79e-05	0.000242	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.76e-05	0.000239	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	2.76e-05	0.000239	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.76e-05	0.000239	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.74e-05	0.000238	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	2.74e-05	0.000237	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.73e-05	0.000237	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.73e-05	0.000237	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.7e-05	0.000234	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	2.7e-05	0.000234	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.7e-05	0.000234	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.68e-05	0.000233	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.67e-05	0.000232	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	2.66e-05	0.000231	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.65e-05	0.00023	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.65e-05	0.000229	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.62e-05	0.000227	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	2.61e-05	0.000226	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.6e-05	0.000225	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.56e-05	0.000222	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	2.56e-05	0.000222	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	2.54e-05	0.00022	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	2.51e-05	0.000217	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	2.51e-05	0.000217	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.49e-05	0.000216	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	2.49e-05	0.000216	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	2.46e-05	0.000213	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	2.44e-05	0.000212	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	2.44e-05	0.000212	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	2.44e-05	0.000212	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.44e-05	0.000211	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	2.43e-05	0.00021	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.39e-05	0.000207	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	2.38e-05	0.000207	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	2.36e-05	0.000204	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.34e-05	0.000203	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.33e-05	0.000202	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.29e-05	0.000199	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	2.29e-05	0.000198	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	2.24e-05	0.000194	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	2.19e-05	0.00019	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	2.19e-05	0.00019	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	2.19e-05	0.00019	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.18e-05	0.000189	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.18e-05	0.000189	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.18e-05	0.000189	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	2.15e-05	0.000186	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.14e-05	0.000185	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.14e-05	0.000185	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.13e-05	0.000185	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.13e-05	0.000185	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.13e-05	0.000185	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	2.13e-05	0.000185	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.13e-05	0.000184	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.11e-05	0.000183	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.09e-05	0.000181	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.09e-05	0.000181	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.09e-05	0.000181	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	2.09e-05	0.000181	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.06e-05	0.000179	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.01e-05	0.000174	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	2e-05	0.000174	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.98e-05	0.000172	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.98e-05	0.000172	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.97e-05	0.00017	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.93e-05	0.000167	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.9e-05	0.000165	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.9e-05	0.000165	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.9e-05	0.000165	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.86e-05	0.000161	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	1.82e-05	0.000158	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.79e-05	0.000155	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	1.78e-05	0.000154	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.76e-05	0.000153	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.76e-05	0.000153	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.75e-05	0.000152	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.75e-05	0.000152	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.72e-05	0.000149	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.72e-05	0.000149	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.72e-05	0.000149	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.67e-05	0.000145	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.64e-05	0.000142	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.64e-05	0.000142	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.64e-05	0.000142	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.63e-05	0.000141	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.61e-05	0.000139	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.6e-05	0.000138	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.6e-05	0.000138	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.56e-05	0.000135	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.56e-05	0.000135	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.56e-05	0.000135	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.52e-05	0.000132	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.5e-05	0.00013	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.49e-05	0.000129	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.47e-05	0.000127	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.46e-05	0.000126	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.45e-05	0.000126	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.42e-05	0.000123	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.4e-05	0.000121	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.37e-05	0.000119	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.36e-05	0.000118	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.35e-05	0.000117	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.34e-05	0.000116	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.34e-05	0.000116	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.33e-05	0.000115	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.32e-05	0.000114	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.32e-05	0.000114	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.28e-05	0.000111	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.27e-05	0.00011	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.27e-05	0.00011	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.25e-05	0.000109	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.25e-05	0.000109	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.25e-05	0.000108	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.24e-05	0.000108	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.24e-05	0.000107	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.23e-05	0.000107	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.22e-05	0.000105	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.18e-05	0.000102	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.16e-05	0.0001	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.15e-05	9.97e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.13e-05	9.76e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.09e-05	9.43e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.07e-05	9.25e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.06e-05	9.15e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.04e-05	8.98e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.03e-05	8.95e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.01e-05	8.78e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	9.78e-06	8.48e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	9.36e-06	8.11e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	9.36e-06	8.11e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	8.56e-06	7.42e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.96e-06	6.9e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.79e-06	6.75e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.34e-06	6.36e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.18e-06	6.22e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.3e-06	3.73e-05	CbGpPWpGaD
